American Journal of Kidney Diseases
Volume 51, Issue 3 , Pages 385-394 , March 2008

Serum Cystatin C in the United States: The Third National Health and Nutrition Examination Survey (NHANES III)

  • Anna Köttgen, MD, MPH

      Affiliations

    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD
    • ,
  • Elizabeth Selvin, PhD, MPH

      Affiliations

    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD
    • ,
  • Lesley A. Stevens, MD, MS

      Affiliations

    • Division of Nephrology, Tufts-New England Medical Center, Boston, MA
    • ,
  • Andrew S. Levey, MD

      Affiliations

    • Division of Nephrology, Tufts-New England Medical Center, Boston, MA
    • ,
  • Frederick Van Lente, PhD

      Affiliations

    • Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Josef Coresh, MD, PhD

      Affiliations

    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD
    • Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Hospital, Baltimore, MD
    • Department of Medicine, Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Hospital, Baltimore, MD.
    • Corresponding Author InformationAddress correspondence to Josef Coresh, MD, PhD, Welch Center for Prevention, Epidemiology & Clinical Research, 2024 E Monument St, Baltimore, MD 21287.

Received 2 September 2007 ,Accepted 17 November 2007.

References 

  1. Kyhse-Andersen J, Schmidt C, Nordin G, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994;40:1921–1926
  2. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis. 2002;40:221–226
  3. Newman DJ. Cystatin C. Ann Clin Biochem. 2002;39(Pt 2):89–104
  4. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049–2060
  5. Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006;145:237–246
  6. Tenstad O, Roald AB, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest. 1996;56:409–414
  7. Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem. 2000;37(Pt 1):49–59
  8. Finney H, Newman DJ, Thakkar H, Fell JM, Price CP. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child. 2000;82:71–75
  9. Vinge E, Lindergard B, Nilsson-Ehle P, Grubb A. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest. 1999;59:587–592
  10. Sjostrom P, Tidman M, Jones I. Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest. 2005;65:111–124
  11. Norlund L, Fex G, Lanke J, et al. Reference intervals for the glomerular filtration rate and cell-proliferation markers: Serum cystatin C and serum beta 2-microglobulin/cystatin C-ratio. Scand J Clin Lab Invest. 1997;57:463–470
  12. Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C. Impact of thyroid dysfunction on serum cystatin C. Kidney Int. 2003;63:1944–1947
  13. Johnston N, Jernberg T, Lindahl B, et al. Biochemical indicators of cardiac and renal function in a healthy elderly population. Clin Biochem. 2004;37:210–216
  14. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65:1416–1421
  15. National Center for Health Statistics. Plan and operations of the Third National Health and Nutrition Examination Survey, 1988-94 Series 1: Programs and collection procedures. Vital Health Stat. 1994;1:1–407
  16. National Center for Health Statistics. Analytic and Reporting Guidelines: The Third National Health and Nutrition Examination Survey, NHANES III (1988-94). Hyattsville, MD: National Center for Health Statistics Centers for Disease Control and Prevention; 1996;
  17. Apple FS, Parvin CA, Buechler KF, Christenson RH, Wu AH, Jaffe AS. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem. 2005;51:2198–2200
  18. Gunter EW, Lewis BG, Koncikowski SM. 1996 Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Hyattsville, MD: US Department of Health and Human Services, Atlanta, GA and National Center for Health Statistics; 1996;
  19. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–2135
  20. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  21. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  22. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30(suppl 1):S4–S41
  23. Selvin E, Manzi J, Stevens LA, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis. 2007;50:918–926
  24. NHANES III Data Files, Documentation, and Codebooks. http://www.cdc.gov/nchs/about/major/nhanes/nh3data.htmAccessed July 26, 2007
  25. Lohr SL. Sampling Design and Analysis. In: Pacific Grove, CA: Duxbury; 1999;p. 265–267
  26. Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2001;161:1207–1216
  27. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—Measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–2483
  28. Simonsen O, Grubb A, Thysell H. The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest. 1985;45:97–101
  29. Galteau MM, Guyon M, Gueguen R, Siest G. Determination of serum cystatin C: Biological variation and reference values. Clin Chem Lab Med. 2001;39:850–857
  30. Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem. 1997;43(Pt 1):1016–1022
  31. Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C: Implications for the assessment of glomerular filtration rate. Clin Chem. 1998;44:1535–1539
  32. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252
  33. Grubb A, Nyman U, Bjork J, et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the Modification of Diet in Renal Disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem. 2005;51:1420–1431
  34. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51:395–406
  35. Aviv A, Hollenberg NK, Weder AB. Sodium glomerulopathy: Tubuloglomerular feedback and renal injury in African Americans. Kidney Int. 2004;65:361–368
  36. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180–188
  37. El Nahas M, Bello AK. Chronic kidney disease: The global challenge. Lancet. 2005;365:331–340
  38. Khare M, Mohadjer LK, Ezzati-Rice TM, Waksberg J. An Evaluation of Nonresponse Bias in NHANES III, Proceedings of the Section on Survey Research Methods. In: Alexandria, VA: American Statistical Association; 1994;p. 949–954
  39. Rule AD, Bergstralh EJ, Slezak JM, Bergert J, Larson TS. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int. 2006;69:399–405

 Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Marcello Tonelli, MD, University of Alberta) who served as Acting Editor-in-Chief. Details of the journal’s procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

PII: S0272-6386(07)01595-8

doi: 10.1053/j.ajkd.2007.11.019

American Journal of Kidney Diseases
Volume 51, Issue 3 , Pages 385-394 , March 2008

Article Tools

* Image Usage & Resolution